It is estimated that 70% to 80% 1 of small molecule drug candidates in development today can be classified as poorly water-soluble. Since poorly soluble drugs are difficult to formulate as tablets, ...
The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback